Home Cart 0 Sign in  
X

[ CAS No. 19163-24-7 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 19163-24-7
Chemical Structure| 19163-24-7
Chemical Structure| 19163-24-7
Structure of 19163-24-7 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 19163-24-7 ]

Related Doc. of [ 19163-24-7 ]

Alternatived Products of [ 19163-24-7 ]

Product Details of [ 19163-24-7 ]

CAS No. :19163-24-7 MDL No. :MFCD01313432
Formula : C11H8O2S Boiling Point : -
Linear Structure Formula :- InChI Key :QGMFBCDNJUZQBZ-UHFFFAOYSA-N
M.W : 204.25 Pubchem ID :736494
Synonyms :

Calculated chemistry of [ 19163-24-7 ]

Physicochemical Properties

Num. heavy atoms : 14
Num. arom. heavy atoms : 11
Fraction Csp3 : 0.0
Num. rotatable bonds : 2
Num. H-bond acceptors : 2.0
Num. H-bond donors : 1.0
Molar Refractivity : 56.71
TPSA : 65.54 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : Yes
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -5.33 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.82
Log Po/w (XLOGP3) : 3.12
Log Po/w (WLOGP) : 3.11
Log Po/w (MLOGP) : 2.24
Log Po/w (SILICOS-IT) : 3.56
Consensus Log Po/w : 2.77

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 0.0
Bioavailability Score : 0.56

Water Solubility

Log S (ESOL) : -3.52
Solubility : 0.0615 mg/ml ; 0.000301 mol/l
Class : Soluble
Log S (Ali) : -4.17
Solubility : 0.014 mg/ml ; 0.0000684 mol/l
Class : Moderately soluble
Log S (SILICOS-IT) : -3.56
Solubility : 0.0559 mg/ml ; 0.000274 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 2.4

Safety of [ 19163-24-7 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P280-P305+P351+P338 UN#:N/A
Hazard Statements:H302-H315-H319-H332-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 19163-24-7 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 19163-24-7 ]
  • Downstream synthetic route of [ 19163-24-7 ]

[ 19163-24-7 ] Synthesis Path-Upstream   1~23

  • 1
  • [ 14597-62-7 ]
  • [ 19163-24-7 ]
YieldReaction ConditionsOperation in experiment
97.1% With sodium hydroxide; water In tetrahydrofuran; methanol for 2 h; To a solution of 2-methoxycarbonyl-5-phenylthiophene (437 mg) in methanol (5 ml) and tetrahydrofuran (5 ml) was added an aqueous solution of sodium hydroxide (IN, 3 ml) followed by stirring for 2 hours..
To the mixture was added hydrochloric acid (IN, 5 ml)..
The precipitate was collected by filtration and dried to give 5-phenylthiophene-2-carboxylic acid (397 mg, 97.1percent).NMR (DMSO-d6, δ): 7.3-7.5 (3H, m), 7.58 1(1H, d, J=3.9 Hz), 7.6-7.8 (3H, m), 13.15 (1H, broad s) ESI-Mass m/z: 203 (M-1).
91.7% With sodium hydroxide In methanol at 20℃; for 4 h; General procedure: Sodium hydroxide (2N) was added to a solution of intermediate 2a-i (1 equiv.) in methanol at ambient temperature. The reaction mixture was stirred for 4h and the methanol was removed by rotary evaporation. The resultant mixture was adjusted to pH=5–6 with 1N HCl solution. The precipitated white solid was collected by filtration and dried to give the carboxylic acid intermediate (1a-i).
Reference: [1] Patent: US6770667, 2004, B1, . Location in patent: Page column 11
[2] ChemMedChem, 2011, vol. 6, # 2, p. 362 - 377
[3] European Journal of Medicinal Chemistry, 2017, vol. 137, p. 96 - 107
[4] Journal of Medicinal Chemistry, 2010, vol. 53, # 15, p. 5536 - 5548
  • 2
  • [ 7311-63-9 ]
  • [ 98-80-6 ]
  • [ 19163-24-7 ]
Reference: [1] Journal of the American Chemical Society, 2009, vol. 131, # 45, p. 16346 - 16347
[2] Bioorganic and Medicinal Chemistry Letters, 2004, vol. 14, # 19, p. 4915 - 4918
[3] Patent: US6399656, 2002, B1,
[4] Patent: WO2006/57922, 2006, A2, . Location in patent: Page/Page column 54-55
  • 3
  • [ 825-55-8 ]
  • [ 124-38-9 ]
  • [ 19163-24-7 ]
Reference: [1] Organic Letters, 2016, vol. 18, # 11, p. 2576 - 2579
[2] Bulletin of the Chemical Society of Japan, 2012, vol. 85, # 3, p. 369 - 371
[3] Molecules, 2018, vol. 23, # 4,
  • 4
  • [ 825-55-8 ]
  • [ 19163-24-7 ]
Reference: [1] Journal of the American Chemical Society, 1954, vol. 76, p. 4450,4452
[2] Patent: US4024156, 1977, A,
  • 5
  • [ 649569-52-8 ]
  • [ 19163-24-7 ]
Reference: [1] Bioorganic and Medicinal Chemistry, 2003, vol. 11, # 22, p. 4729 - 4742
  • 6
  • [ 19163-21-4 ]
  • [ 19163-24-7 ]
  • [ 500604-89-7 ]
YieldReaction ConditionsOperation in experiment
51% With sodium hydroxide; potassium dihydrogenphosphate; NaClO2 In tetrahydrofuran; water; <i>tert</i>-butyl alcohol 5-Phenylthiophene-2-carboxaldehyde (750 mg, 4 mmol) is dissolved in a mixture of THF, tBuOH, and water (2:1:1, 60 mL). KH2PO4 (1.36 g, 10 mmol) is added followed by NaClO2 (900 mg, 10 mmol).
The mixture is stirred at rt for 5 days.
Aqueous NaOH (2M, 10 mL) is added and a majority of the organic solvents are removed in vacuo yielding an aqueous suspension.
This suspension is diluted with water and washed with three times with CH2Cl2.
The aqueous layer is acidified to pH<2 with 25percent H2SO4 and the product is extracted three times with CH2Cl2.
The combined organic washes are dried over Na2SO4, filtered and concentrated in vacuo to yield 417 mg (51percent) of 5-phenylthiophene-2-carboxylic acid. MS for C11H8O2S, (ES) m/z: 203 (M-H)-.
Reference: [1] Patent: US2003/69290, 2003, A1,
  • 7
  • [ 1383628-95-2 ]
  • [ 19163-24-7 ]
Reference: [1] Journal of Medicinal Chemistry, 2012, vol. 55, # 12, p. 5982 - 5986
  • 8
  • [ 98-80-6 ]
  • [ 19163-24-7 ]
Reference: [1] Journal of Medicinal Chemistry, 1997, vol. 40, # 11, p. 1585 - 1599
[2] Heterocycles, 2014, vol. 89, # 2, p. 453 - 464
[3] European Journal of Medicinal Chemistry, 2017, vol. 137, p. 96 - 107
  • 9
  • [ 19163-21-4 ]
  • [ 19163-24-7 ]
Reference: [1] Journal of Medicinal Chemistry, 1997, vol. 40, # 11, p. 1585 - 1599
[2] Heterocycles, 2014, vol. 89, # 2, p. 453 - 464
  • 10
  • [ 4701-17-1 ]
  • [ 19163-24-7 ]
Reference: [1] Journal of Medicinal Chemistry, 1997, vol. 40, # 11, p. 1585 - 1599
[2] Heterocycles, 2014, vol. 89, # 2, p. 453 - 464
  • 11
  • [ 10341-87-4 ]
  • [ 19163-24-7 ]
Reference: [1] Journal of the American Chemical Society, 1954, vol. 76, p. 4450,4452
  • 12
  • [ 76576-48-2 ]
  • [ 19163-24-7 ]
Reference: [1] Journal of the American Chemical Society, 1954, vol. 76, p. 4450,4452
  • 13
  • [ 824-90-8 ]
  • [ 19163-24-7 ]
Reference: [1] Journal of the American Chemical Society, 1954, vol. 76, p. 4450,4452
  • 14
  • [ 24065-33-6 ]
  • [ 98-80-6 ]
  • [ 19163-24-7 ]
Reference: [1] Organometallics, 2017, vol. 36, # 21, p. 4191 - 4201
  • 15
  • [ 15289-17-5 ]
  • [ 19163-24-7 ]
Reference: [1] Bioorganic and Medicinal Chemistry, 2003, vol. 11, # 22, p. 4729 - 4742
  • 16
  • [ 310463-02-6 ]
  • [ 19163-24-7 ]
Reference: [1] Bioorganic and Medicinal Chemistry, 2003, vol. 11, # 22, p. 4729 - 4742
  • 17
  • [ 99846-01-2 ]
  • [ 19163-24-7 ]
Reference: [1] Journal of Organic Chemistry, 1956, vol. 21, p. 32,35
[2] Journal of Organic Chemistry, 1956, vol. 21, p. 32,35
  • 18
  • [ 69202-28-4 ]
  • [ 19163-24-7 ]
Reference: [1] Pharmaceutical Chemistry Journal, 1978, vol. 12, # 11, p. 1448 - 1451[2] Khimiko-Farmatsevticheskii Zhurnal, 1978, vol. 12, # 11, p. 53 - 56
  • 19
  • [ 62224-19-5 ]
  • [ 19163-24-7 ]
Reference: [1] European Journal of Medicinal Chemistry, 2017, vol. 137, p. 96 - 107
  • 20
  • [ 26036-50-0 ]
  • [ 19163-24-7 ]
Reference: [1] Journal of Organic Chemistry, 1956, vol. 21, p. 32,35
  • 21
  • [ 62224-19-5 ]
  • [ 98-80-6 ]
  • [ 19163-24-7 ]
Reference: [1] ChemMedChem, 2011, vol. 6, # 2, p. 362 - 377
  • 22
  • [ 13781-37-8 ]
  • [ 19163-24-7 ]
Reference: [1] Biochemische Zeitschrift, 1937, vol. 292, p. 368
  • 23
  • [ 64-17-5 ]
  • [ 26036-50-0 ]
  • [ 7553-56-2 ]
  • [ 19163-24-7 ]
Reference: [1] Journal of Organic Chemistry, 1956, vol. 21, p. 32,35
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 19163-24-7 ]

Aryls

Chemical Structure| 29886-63-3

[ 29886-63-3 ]

3-(Thiophen-2-yl)benzoic acid

Similarity: 0.81

Chemical Structure| 1261976-11-7

[ 1261976-11-7 ]

5-(4-Hydroxy-3-methylphenyl)thiophene-2-carbaldehyde

Similarity: 0.79

Chemical Structure| 102016-58-0

[ 102016-58-0 ]

3-(4-(Methylthio)phenyl)acrylic acid

Similarity: 0.76

Chemical Structure| 99902-07-5

[ 99902-07-5 ]

2-(Thiophen-2-yl)benzaldehyde

Similarity: 0.75

Chemical Structure| 107834-03-7

[ 107834-03-7 ]

4-(Thiophen-2-yl)benzaldehyde

Similarity: 0.75

Carboxylic Acids

Chemical Structure| 6314-28-9

[ 6314-28-9 ]

Benzo[b]thiophene-2-carboxylic acid

Similarity: 0.95

Chemical Structure| 1467-86-3

[ 1467-86-3 ]

6-Methylbenzo[b]thiophene-2-carboxylic acid

Similarity: 0.95

Chemical Structure| 1735-13-3

[ 1735-13-3 ]

4-Methylbenzo[b]thiophene-2-carboxylic acid

Similarity: 0.87

Chemical Structure| 26018-73-5

[ 26018-73-5 ]

6-Chlorobenzo[b]thiophene-2-carboxylic acid

Similarity: 0.81

Chemical Structure| 29886-63-3

[ 29886-63-3 ]

3-(Thiophen-2-yl)benzoic acid

Similarity: 0.81